| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |

,
*
Division of Nephrology and Hypertension, Georgetown University Medical
Center, Washington, DC
Division of Cardiology, University of Florida College of Medicine,
Gainesville, Florida
C V Therapeutics, Palo Alto, California.
Correspondence to Dr. Christopher S. Wilcox, George E. Schreiner Professor and Chief, Division of Nephrology and Hypertension, Georgetown University Medical Center, 3800 Reservoir Road, NW, PHC F6003, Washington, DC 20007. Phone: 202-687-8539; Fax: 202-687-7893; E-mail: wilcoxch{at}gunet.georgetown.edu
Abstract. The natriuretic and diuretic action of a highly
selective adenosine A1 receptor (A1AdoR) antagonist,
1,3-dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine (CVT-124), was investigated in
anesthetized rats. CVT-124 (0.1 to 1 mg/kg) caused dose-dependent increases in
urine flow and fractional and absolute sodium excretion of by six- to 10-fold
and, at 0.1 mg/kg, increased the GFR (1.6 ± 0.1 to 2.5 ± 0.2
ml/min; P < 0.01). There were no changes in BP or heart rate.
CVT-124 reduced absolute proximal reabsorption (26 ± 3 to 20 ± 2
nl/min; P < 0.05) despite unchanged proximally measured,
single-nephron GFR (SNGFR) (42 ± 5 to 44 ± 4 nl/min; NS) and
thereby decreased fractional proximal reabsorption (60 ± 3 to 46
± 4%; P < 0.05). Despite increasing distal tubular fluid
flow rate (5.4 ± 0.7 to 9.7 ± 0.9 nl/min; P <
0.001), it reduced the proximal-distal difference in SNGFR (before: 9.4
± 1.0 versus during CVT-124: 4.6 ± 1.5 nl/min;
P < 0.01), suggesting that it had blunted the effects of the
macula densa on SNGFR. Direct measurements of maximal tubuloglomerular
feedback (TGF) responses were made from proximal stop flow pressure (PSF)
during orthograde loop perfusion from the proximal tubule with artificial
tubular fluid at 40 nl/min. TGF was blunted by intravenous CVT-124 (0.5 mg/kg;
PSF with vehicle: 8.3 ± 0.6 versus CVT-124: 6.5 ±
0.3 mmHg; n = 9; P < 0.01). In conclusion,
A1AdoR blockade reduces proximal reabsorption and uncouples it from
glomerular filtration. It increases distal delivery of fluid yet does not
activate a macula densa-dependent fall in SNGFR because it blunts the TGF
response. Natriuresis accompanied by blockade of proximal glomerulotubular
balance and TGF characterizes a new class of diuretic drugs.
This article has been cited by other articles:
![]() |
A. Kulick, C. Panico, P. Gill, and W. J. Welch Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule Am J Physiol Renal Physiol, July 1, 2008; 295(1): F37 - F41. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Castrop Modulation of adenosine receptor expression in the proximal tubule: a novel adaptive mechanism to regulate renal salt and water metabolism Am J Physiol Renal Physiol, July 1, 2008; 295(1): F35 - F36. [Full Text] [PDF] |
||||
![]() |
R. D. Brown, P. Thoren, A. Steege, R. Mrowka, J. Sallstrom, O. Skott, B. B. Fredholm, and A. E. G. Persson Influence of the adenosine A1 receptor on blood pressure regulation and renin release Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1324 - R1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Deng, C. M. Miracle, M. Lortie, J. Satriano, F. B. Gabbai, K. A. Munger, S. C. Thomson, and R. C. Blantz Kidney oxygen consumption, carbonic anhydrase, and proton secretion Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1009 - F1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou and C. K. Kost Jr. Adenosine A1 Receptor Antagonist Blunts Urinary Potassium Excretion, but Not Renal Hemodynamic Effects, Induced by Carbonic Anhydrase Inhibitor in Rats J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 530 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Vekaria, D. G. Shirley, J. Sevigny, and R. J. Unwin Immunolocalization of ectonucleotidases along the rat nephron Am J Physiol Renal Physiol, February 1, 2006; 290(2): F550 - F560. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. McLaughlin and C. L. Abitbol Reversal of oliguric tacrolimus nephrotoxicity in children Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1471 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rieg, H. Steigele, J. Schnermann, K. Richter, H. Osswald, and V. Vallon Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 403 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hashimoto, J. W. Adams, K. E. Bernstein, and J. Schnermann Micropuncture determination of nephron function in mice without tissue angiotensin-converting enzyme Am J Physiol Renal Physiol, March 1, 2005; 288(3): F445 - F452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bak and K. Thomsen Effects of the adenosine A1 receptor inhibitor FK 838 on proximal tubular fluid output in rats Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1077 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Auchampach, X. Jin, J. Moore, T. C. Wan, L. M. Kreckler, Z.-D. Ge, J. Narayanan, E. Whalley, W. Kiesman, B. Ticho, et al. Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 846 - 856. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Bucheimer and J. Linden Purinergic regulation of epithelial transport J. Physiol., March 1, 2004; 555(2): 311 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hansen and J. Schnermann Vasoconstrictor and vasodilator effects of adenosine in the kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schweda, C. Wagner, B. K. Kramer, J. Schnermann, and A. Kurtz Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice Am J Physiol Renal Physiol, April 1, 2003; 284(4): F770 - F777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gottlieb, D. C. Brater, I. Thomas, E. Havranek, R. Bourge, S. Goldman, F. Dyer, M. Gomez, D. Bennett, B. Ticho, et al. BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy Circulation, March 19, 2002; 105(11): 1348 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox New Insights into Diuretic Use in Patients with Chronic Renal Disease J. Am. Soc. Nephrol., March 1, 2002; 13(3): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson, C. K. Kost Jr., W. A. Herzer, G. J. Smits, and S. P. Tofovic A1 Receptor Blockade Induces Natriuresis with a Favorable Renal Hemodynamic Profile in SHHF/Mcc-facp Rats Chronically Treated with Salt and Furosemide J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 978 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Buschhausen, S. Seibold, O. Gross, T. Matthaeus, M. Weber, and E. Schulze-Lohoff Regulation of mesangial cell function by vasodilatory signaling molecules Cardiovasc Res, August 15, 2001; 51(3): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sun, L. C. Samuelson, T. Yang, Y. Huang, A. Paliege, T. Saunders, J. Briggs, and J. Schnermann Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors PNAS, August 14, 2001; 98(17): 9983 - 9988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, E. W. Inscho, and L. G. Navar Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity Am J Physiol Renal Physiol, March 1, 2001; 280(3): F406 - F414. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, D. S. A. Majid, M. Walker III, A. Miyatake, and L. G. Navar Renal Interstitial ATP Responses to Changes in Arterial Pressure During Alterations in Tubuloglomerular Feedback Activity Hypertension, February 1, 2001; 37(2): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. TAKEZAKO, K. NODA, E. TSUJI, M. KOGA, M. SASAGURI, and K. ARAKAWA Adenosine Activates Aromatic L-Amino Acid Decarboxylase Activity in the Kidney and Increases Dopamine J. Am. Soc. Nephrol., January 1, 2001; 12(1): 29 - 36. [Abstract] [Full Text] |
||||
![]() |
C. K. Kost Jr., W. A. Herzer, B. R. Rominski, Z. Mi, and E. K. Jackson Diuretic Response to Adenosine A1 Receptor Blockade in Normotensive and Spontaneously Hypertensive Rats: Role of Pertussis Toxin-Sensitive G-Proteins J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 752 - 760. [Abstract] [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673